NAI SATURN EASTERN LLC NPI 1538565478

NPI Information

  • NPI: 1538565478
  • Provider Name: NAI SATURN EASTERN LLC
  • Classification: Pharmacy - 3336C0003X
  • Specialization: Community/Retail Pharmacy
  • Entity Type: Organization
  • Doing Business As: SAFEWAY PHARMACY
  • Address: 250 E PARKCENTER BLVD
    BOISE, ID
    ZIP 83706
  • Phone: (208) 395-6200

Map and Directions

Get Directions

NPI Details

NAI SATURN EASTERN LLC is a community/retail pharmacy pharmacy in Boise, ID. The provider is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes. NAI SATURN EASTERN LLC NPI is 1538565478. The provider is registered as an organization entity type.
The provider Is Doing Business As Safeway Pharmacy.

The provider's business location address is:

250 E PARKCENTER BLVD
BOISE, ID
ZIP 83706-940
Phone: (208) 395-6200

The provider's authorized official is Kathy Giannakopoulos .
The authorized official title is Enrollments Manager and has the following contact phone number (208) 395-3954.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Fee covid-19 vac 13 res (HCPCS:0124A)
  • Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
  • Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
  • Fee covid-19 vac 14 res (HCPCS:0134A)
  • Administration of pneumococcal vaccine (HCPCS:G0009)
  • Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
  • Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
  • Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
  • Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
  • Pneumococcal vaccine, 23-valent (HCPCS:90732)
  • Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
  • Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
  • Adm sarscv2 30mcg trs-sucr 2 (HCPCS:0052A)
  • Adm sarscov2 vac ad26 .5ml b (HCPCS:0034A)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)
  • Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
  • Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
  • Adm sarscv2 30mcg trs-sucr 1 (HCPCS:0051A)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose (HCPCS:0002A)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
  • Pneumococcal vaccine, 13-valent (HCPCS:90670)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, single dose (HCPCS:0031A)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage; first dose (HCPCS:0041A)
  • Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage; second dose (HCPCS:0042A)

The enumeration date for this NPI number is 11/4/2014 and was last updated on 4/24/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1332B00000XDurable Medical Equipment & Medical SuppliesNo
2333600000XPharmacyNo
33336C0003XPharmacyCommunity/Retail PharmacyYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.